1156 related articles for article (PubMed ID: 12580710)
1. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
2. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
Kupersmith MJ; Ying G
Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
[TBL] [Abstract][Full Text] [Related]
3. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
[TBL] [Abstract][Full Text] [Related]
4. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
Kupersmith MJ
J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
6. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and prognosis of myasthenia gravis in older people.
Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
J Am Geriatr Soc; 2000 Nov; 48(11):1442-8. PubMed ID: 11083321
[TBL] [Abstract][Full Text] [Related]
8. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting outcome in ocular myasthenia gravis.
Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis with ocular involvement in older patients.
Weizer JS; Lee AG; Coats DK
Can J Ophthalmol; 2001 Feb; 36(1):26-33. PubMed ID: 11227387
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
Fisher KS; Gill J; Todd HF; Yang MB; Lopez MA; Abid F; Lotze T; Shah VS
Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
[TBL] [Abstract][Full Text] [Related]
12. Detectable voice change with the edrophonium test in laryngeal myasthenia gravis.
Tsunoda K; Fujimaki Y; Morita Y
J Int Med Res; 2017 Oct; 45(5):1466-1469. PubMed ID: 28379106
[TBL] [Abstract][Full Text] [Related]
13. Dropped head with positive intravenous edrophonium, progressing to myasthenia gravis.
Sawa N; Kataoka H; Eura N; Ueno S
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23376659
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
[TBL] [Abstract][Full Text] [Related]
15. Clinical analysis of Chinese anti-low-density-lipoprotein-receptor-associated protein 4 antibodies in patients with myasthenia gravis.
Li M; Han J; Zhang Y; Lv J; Zhang J; Zhao X; Ren L; Fang H; Yang J; Zhang Y; Cui X; Zhang Q; Li Q; Du Y; Gao F
Eur J Neurol; 2019 Oct; 26(10):1296-e84. PubMed ID: 31050101
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and follow-up management of 135 children with myasthenia gravis].
Yang ZX; Xiong H; Zhang YH; Bao XH; Jiang YW; Wu Y; Wang S; Chang XZ; Qin J; Lin Q; Wu XR
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):455-9. PubMed ID: 21681282
[TBL] [Abstract][Full Text] [Related]
17. Discordant thymectomy in identical twins concordant for myasthenia gravis.
Riggs KR; Gutmann L; Riggs JE
Ann Intern Med; 2011 Oct; 155(7):478-9. PubMed ID: 21969350
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: outcomes in 102 patients.
Hehir MK; Burns TM; Alpers J; Conaway MR; Sawa M; Sanders DB
Muscle Nerve; 2010 May; 41(5):593-8. PubMed ID: 20405499
[TBL] [Abstract][Full Text] [Related]
19. Childhood myasthenia gravis: clinical features and outcomes.
Sri-udomkajorn S; Panichai P; Liumsuwan S
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
[TBL] [Abstract][Full Text] [Related]
20. The high frequency and clinical feature of seronegative myasthenia gravis in Southern China.
Feng HY; Wang HY; Liu WB; He XT; Huang X; Luo CM; Li Y
Neurol Sci; 2013 Jun; 34(6):919-24. PubMed ID: 22829131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]